Cerebral tau is elevated after aneurysmal subarachnoid haemorrhage and associated with brain metabolic distress and poor functional and cognitive long-term outcome

Background Recent evidence suggests axonal injury after aneurysmal subarachnoid haemorrhage (aSAH). The microtubule-associated protein, tau, has been shown to be elevated in the cerebrospinal fluid after aSAH, however, brain extracellular tau levels and their relation to long-term neurological and cognitive outcomes have not been investigated. Methods Serial cerebral microdialysis (CMD) samples were collected from 22 consecutive aSAH patients with multimodal neuromonitoring to determine CMD-total-tau by ELISA. CMD-total-tau was analysed considering other brain metabolic parameters, brain tissue oxygen tension (PbtO2), and functional and neuropsychological outcome at 12 months. All outcome models were analysed using generalised estimating equations with an autoregressive working correlation matrix to account for multiple measurements of brain extracellular proteins per subject. Results CMD-total-tau levels positively correlated with brain extracellular fluid levels of lactate (r=0.40, p<0.001), glutamate (r=0.45, p<0.001), pyruvate (r=0.26, p<0.001), and the lactate-pyruvate ratio (r=0.26, p<0.001), and were higher in episodes of hypoxic (PbtO2<20 mm Hg) brain extracellular lactate elevation (>4 mmol/L) (p<0.01). More importantly, high CMD-total-tau levels were associated with poor functional outcome (modified Rankin Scale ≥4) 12 months after aSAH even after adjusting for disease severity and age (p=0.001). A similar association was found with 3/5 neuropsychological tests indicative of impairments in cognition, psychomotor speed, visual conceptualisation and frontal executive functions at 1 year after aSAH (p<0.01). Conclusions These results suggest that CMD-total tau may be an important biomarker for predicting long-term outcome in patients with severe aSAH. The value of axonal injury needs further confirmation in a larger patient cohort, preferably combined with advanced imaging techniques.

[1]  Marvin Bergsneider,et al.  Metabolic Crisis without Brain Ischemia is Common after Traumatic Brain Injury: A Combined Microdialysis and Positron Emission Tomography Study , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  S. Peery,et al.  Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage , 2002, Neurology.

[3]  N. Hirokawa,et al.  Sorting mechanisms of Tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule binding , 1995, Neuron.

[4]  S. Mayer,et al.  Global Cerebral Edema After Subarachnoid Hemorrhage: Frequency, Predictors, and Impact on Outcome , 2002, Stroke.

[5]  M. Ptok,et al.  Verbaler Lern- und Merkfähigkeitstest , 2005, HNO (Berlin. Print).

[6]  P. Magistretti,et al.  Brain Lactate Metabolism in Humans With Subarachnoid Hemorrhage , 2012, Stroke.

[7]  D. Hovda,et al.  Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. , 2005, Journal of neurotrauma.

[8]  R. Hayes,et al.  Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. , 2007, Journal of neurosurgery.

[9]  R. Bateman,et al.  Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  John H. Zhang,et al.  Mechanisms of Early Brain Injury after Subarachnoid Hemorrhage , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  G Keir,et al.  Axonal damage and outcome in subarachnoid haemorrhage , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  N. Offenhauser,et al.  Spreading ischemia after aneurysmal subarachnoid hemorrhage. , 2013, Acta neurochirurgica. Supplement.

[13]  Jan Claassen,et al.  TRANSCRANIAL DOPPLER FOR PREDICTING DELAYED CEREBRAL ISCHEMIA AFTER SUBARACHNOID HEMORRHAGE , 2009, Neurosurgery.

[14]  T. Schweizer,et al.  Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage , 2010, Stroke.

[15]  C. V. van Heugten,et al.  Prevalence and Determinants of Cognitive Complaints after Aneurysmal Subarachnoid Hemorrhage , 2010, Cerebrovascular Diseases.

[16]  L. Puybasset,et al.  S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage* , 2008, Critical care medicine.

[17]  Ale Algra,et al.  Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis , 2009, The Lancet Neurology.

[18]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[19]  E. Niskanen,et al.  Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study , 2009, Neuroradiology.

[20]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[21]  T. Tombaugh.  Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[22]  E. Thompson,et al.  Temporal Alterations in Cerebrospinal Fluid Amyloid &bgr;-Protein and Apolipoprotein E After Subarachnoid Hemorrhage , 2003, Stroke.

[23]  E. Niskanen,et al.  Atrophic Enlargement of CSF Volume after Subarachnoid Hemorrhage: Correlation with Neuropsychological Outcome , 2010, American Journal of Neuroradiology.

[24]  S. Mayer,et al.  Cerebral Perfusion Pressure Thresholds for Brain Tissue Hypoxia and Metabolic Crisis After Poor-Grade Subarachnoid Hemorrhage , 2011, Stroke.

[25]  C. Polman,et al.  Biological markers in CSF and blood for axonal degeneration in multiple sclerosis , 2005, The Lancet Neurology.

[26]  J. Pickard,et al.  The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  D. Holtzman,et al.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. , 2012, Brain : a journal of neurology.

[28]  D. Arciniegas,et al.  Clock-drawing performance predicts inpatient rehabilitation outcomes after traumatic brain injury. , 2011, The Journal of neuropsychiatry and clinical neurosciences.

[29]  D. Royall,et al.  CLOX: an executive clock drawing task , 1998, Journal of neurology, neurosurgery, and psychiatry.

[30]  Aman B Patel,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association , 1994, Stroke.

[31]  A. Algra,et al.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage , 2011, The Lancet Neurology.

[32]  M. Seipelt,et al.  Serum Tau Protein Level as a Marker of Axonal Damage in Acute Ischemic Stroke , 2002, European Neurology.

[33]  W. Thies,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.

[34]  N. Stocchetti,et al.  Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. , 2013, British journal of anaesthesia.

[35]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[36]  J. Pickard,et al.  Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. , 2011, Brain : a journal of neurology.

[37]  J. Jhamandas,et al.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. , 2013, Journal of psychiatry & neuroscience : JPN.

[38]  D. Cicchetti,et al.  Cognitive Functioning in Patients with Cerebral Aneurysms Measured with the Mini Mental State Examination and the Telephone Interview for Cognitive Status , 2006, Neurosurgery.

[39]  S. Mayer,et al.  Global Cerebral Edema and Brain Metabolism After Subarachnoid Hemorrhage , 2011 .

[40]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[41]  Jia Li,et al.  Biomarkers associated with diffuse traumatic axonal injury: exploring pathogenesis, early diagnosis, and prognosis. , 2010, The Journal of trauma.